Lv1
6 积分 2024-02-29 加入
DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B
2个月前
已完结
DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish
2个月前
已完结
基于组织病理学特征的结直肠癌预后及术后肝转移相关性研究
2个月前
已完结
SMARCA4-deficient undifferentiated gastric carcinoma: a case series and literature review
3个月前
已完结
SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction
3个月前
已完结
胃癌周围神经侵犯的预后分析及风险预测
3个月前
已完结
Perfusable adipose decellularized extracellular matrix biological scaffold co-recellularized with adipose-derived stem cells and L6 promotes functional skeletal muscle regeneration following volumetric muscle loss
4个月前
已完结
直肠癌新辅助治疗研究进展与展望
4个月前
已完结
[Helicobacter pylori eradication therapy with omeprazole and amoxicillin: current status]
4个月前
已关闭
Advancements in immunotherapy for gastric cancer: Unveiling the potential of immune checkpoint inhibitors and emerging strategies
4个月前
已完结
皖公网安备34019202002308
